Industry

The company’s impact strategy is driven by the vision of transforming health care in 100+ communities through a sustainable value-based primary care model AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today released its inaugural Total Care, Healthier Communities Impact Report highlighting the company’s … [Read more…]

Study from the Tisch Multiple Sclerosis Research Center of New York shows importance of analyzing T-cell response in COVID vaccines, particularly for immunocompromised individuals NEW YORK–(BUSINESS WIRE)–New research, published in Frontiers in Immunology and conducted by the Tisch Multiple Sclerosis Research Center of New York, has found that multiple sclerosis (MS) patients receiving anti-CD20 therapy … [Read more…]

Technology Industry Veteran to Drive Growth, Extend Market Leadership and Drive Improved Healthcare Outcomes LOS ANGELES–(BUSINESS WIRE)–mPulse Mobile, a leader in conversational AI and digital engagement solutions for the healthcare industry, today announced the appointment of Robert “Bob” Farrell as CEO. Mr. Farrell will also join mPulse Mobile’s board of directors. Chris Nicholson, mPulse Mobile’s … [Read more…]

Smartlink Integration, Fueled by WELL Health and Gozio Health, Drives 443% Increase in Daily App Downloads CHAPEL HILL, N.C.–(BUSINESS WIRE)–UNC Health, a not-for-profit integrated health care system owned by the state of North Carolina and based in Chapel Hill, announced today that it is releasing new features within its mobile platform. Partnering with industry leaders, … [Read more…]

Esteemed business leader, Chuck Mooty, joins the Board of Directors for innovative home health technology. MINNEAPOLIS–(BUSINESS WIRE)–Ōmcare announced that Chuck Mooty has joined their Board of Directors. Recently, Mooty was announced as a 2022 Minnesota Business Hall of Fame inductee for his many successes and thoughtful leadership throughout his career. Within a six-year window, Mooty … [Read more…]

– Seralutinib Phase 2 TORREY Study on track for topline readout in second half of November or first half of December – – CNS-penetrant GB5121 doses first patient in Phase 1b/2 STAR CNS Study in PCNSL and other rare CNS malignancies – – $342 million in cash, cash equivalents & marketable securities, as of June … [Read more…]

Mirion Technologies acquires Critical Infrastructure business of Collins Aerospace to expand capabilities in software, cybersecurity ATLANTA–(BUSINESS WIRE)–Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), a leading provider of comprehensive systems that detect and monitor radiation in medical, industrial and defense end markets, today announced the acquisition of the Critical Infrastructure (CI) business of Collins Aerospace (through ARINC … [Read more…]

 The Be The Match Registry® includes more than 266,000 fully characterized CBUs, allowing for therapy-matched unit identification. MINNEAPOLIS–(BUSINESS WIRE)–Be The Match BioTherapies® announced it is now providing cryopreserved Cord Blood Units as allogeneic cell therapy starting material for non-clinical, clinical, and commercial use. The Be The Match Registry®, with more than 266,000 fully-characterized cord blood … [Read more…]

Mr. Claiborne Joined the CytRx Board of Directors as of the Annual Meeting LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, welcomes Mr. Cary J. Claiborne to the CytRx Board of Directors (the “Board”). Mr. Claiborne brings to CytRx a wealth … [Read more…]

Company awarded commercial GMP license following successful EMA inspection of Memphis CDMO facility MEMPHIS, Tenn.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories, International Inc. (NYSE: CRL) announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products for distribution in Europe, from the European Medicines Agency … [Read more…]